Intravenous Phage Therapy Reviewed For Difficult Infections

A new systematic review has examined intravenous phage therapy for difficult to treat infections where antibiotics often fail and patients have few remaining options. Phages are viruses that infect bacteria and can target specific strains without harming human cells when carefully selected. The review gathered individual patient data from published cases to assess safety outcomes and treatment response across different hospitals. Researchers looked at bloodstream dosing delivery timing and how patients fared after therapy in real world care. Early results suggest the approach can help selected patients when standard options are limited and resistance blocks progress. Doctors caution that evidence remains early and protocols vary widely across centers and bacterial species. The authors call for larger controlled trials and clearer rules for phage selection dosing and monitoring before wider use.

image
advertisement
"We will never ask you to login, or register through a third-party advertisement."